LumiraDx Price Prediction
LMDXDelisted Stock | USD 0.42 0.02 4.55% |
Oversold Vs Overbought
46
Oversold | Overbought |
Using LumiraDx hype-based prediction, you can estimate the value of LumiraDx from the perspective of LumiraDx response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in LumiraDx to buy its stock at a price that has no basis in reality. In that case, they are not buying LumiraDx because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
LumiraDx after-hype prediction price | USD 0.42 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
LumiraDx |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of LumiraDx's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
LumiraDx After-Hype Price Prediction Density Analysis
As far as predicting the price of LumiraDx at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in LumiraDx or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of LumiraDx, with the unreliable approximations that try to describe financial returns.
Next price density |
Expected price to next headline |
LumiraDx Estimiated After-Hype Price Volatility
In the context of predicting LumiraDx's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on LumiraDx's historical news coverage. LumiraDx's after-hype downside and upside margins for the prediction period are 0.42 and 0.42, respectively. We have considered LumiraDx's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
LumiraDx is very steady at this time. Analysis and calculation of next after-hype price of LumiraDx is based on 3 months time horizon.
LumiraDx Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as LumiraDx is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading LumiraDx backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with LumiraDx, there might be something going there, and it might present an excellent short sale opportunity.
Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 1 Events / Month | 7 Events / Month | Very soon |
Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.42 | 0.42 | 0.00 |
|
LumiraDx Hype Timeline
LumiraDx is now traded for 0.42. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. LumiraDx is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is now at 0.0%. %. The volatility of related hype on LumiraDx is about 0.0%, with the expected price after the next announcement by competition of 0.42. About 55.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 1.08. LumiraDx had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be very soon. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.LumiraDx Related Hype Analysis
Having access to credible news sources related to LumiraDx's direct competition is more important than ever and may enhance your ability to predict LumiraDx's future price movements. Getting to know how LumiraDx's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how LumiraDx may potentially react to the hype associated with one of its peers.
HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
FONR | Fonar | (0.14) | 6 per month | 0.00 | (0.08) | 2.15 | (2.97) | 10.60 | |
BNR | Burning Rock Biotech | 0.35 | 3 per month | 0.00 | (0.04) | 11.63 | (7.67) | 34.58 | |
SERA | Sera Prognostics | 1.07 | 9 per month | 0.00 | (0.04) | 9.55 | (7.61) | 27.67 | |
OLK | Olink Holding AB | 0.01 | 10 per month | 0.48 | 0.05 | 1.58 | (1.37) | 4.37 | |
GTH | Genetron Holdings | (0.02) | 1 per month | 2.49 | (0.04) | 3.45 | (4.08) | 14.43 | |
XGN | Exagen Inc | (0.07) | 8 per month | 3.42 | 0.07 | 9.62 | (6.46) | 25.65 | |
SHC | Sotera Health Co | 0.13 | 8 per month | 0.00 | (0.16) | 3.74 | (3.99) | 13.40 | |
PMD | Psychemedics | (0.02) | 6 per month | 0.51 | (0.14) | 0.87 | (0.87) | 3.46 | |
DRIO | DarioHealth Corp | (0.02) | 10 per month | 0.00 | (0.09) | 8.99 | (7.00) | 27.55 | |
ENZ | Enzo Biochem | 0.02 | 5 per month | 1.32 | (0.06) | 2.97 | (1.94) | 7.62 | |
BDSX | Biodesix | 0.01 | 8 per month | 0.00 | (0.10) | 5.95 | (5.61) | 29.48 |
LumiraDx Additional Predictive Modules
Most predictive techniques to examine LumiraDx price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for LumiraDx using various technical indicators. When you analyze LumiraDx charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
About LumiraDx Predictive Indicators
The successful prediction of LumiraDx stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as LumiraDx, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of LumiraDx based on analysis of LumiraDx hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to LumiraDx's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to LumiraDx's related companies.
Story Coverage note for LumiraDx
The number of cover stories for LumiraDx depends on current market conditions and LumiraDx's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that LumiraDx is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about LumiraDx's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
LumiraDx Short Properties
LumiraDx's future price predictability will typically decrease when LumiraDx's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of LumiraDx often depends not only on the future outlook of the potential LumiraDx's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. LumiraDx's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding | 282.2 M | |
Cash And Short Term Investments | 100 M |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Consideration for investing in LumiraDx Stock
If you are still planning to invest in LumiraDx check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LumiraDx's history and understand the potential risks before investing.
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |